Transcatheter Embolization and Occlusion Devices Market Share, Size, Trends and Growth, By Product Analysis, Application and Segment Forecasts To 2022
The global transcatheter embolization and occlusion devices market is expected to reach over USD 4.75 billion by 2022, according to a new study by Grand View Research, Inc.
The global transcatheter embolization and occlusion devices market is expected to reach over USD 4.75 billion by 2022, according to a new study by Grand View Research, Inc.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Hexa Reports<br />
<strong>Market</strong> Research Reports <strong>and</strong> Insightful Company Profiles<br />
<strong>Transcatheter</strong> <strong>Embolization</strong> <strong>and</strong> <strong>Occlusion</strong> <strong>Devices</strong> <strong>Market</strong><br />
<strong>Share</strong>, <strong>Size</strong>, <strong>Trends</strong> <strong>and</strong> <strong>Growth</strong>, <strong>By</strong> <strong>Product</strong> <strong>Analysis</strong>,<br />
<strong>Application</strong> <strong>and</strong> <strong>Segment</strong> <strong>Forecasts</strong> <strong>To</strong> <strong>2022</strong><br />
The global transcatheter embolization <strong>and</strong> occlusion devices market is expected to reach over USD 4.75<br />
billion by <strong>2022</strong>, according to a new study by Gr<strong>and</strong> View Research, Inc. Key drivers of the market include<br />
increasing adoption of minimally invasive surgeries <strong>and</strong> rising prevalence of cancer.<br />
According to the National Cancer Institute at the National Institute of Health (NIH), around 1,658,370<br />
new cancer cases will be diagnosed <strong>and</strong> around 589,430 people will die in 2015 in the U.S. alone. Taking<br />
into account the increasing prevalence of cancer, the global TEO devices market is anticipated to grow at<br />
a significant growth rate of 10.1% during the forecast period.<br />
Browse Detail Report With TOC @ http://www.hexareports.com/report/transcatheter-embolization<strong>and</strong>-occlusion-devices-market/details<br />
In addition, growth of use of embolization technique as a treatment for conditions other than cancer<br />
such as vascular malformations <strong>and</strong> fibrosis is fueling the dem<strong>and</strong> for TEO devices globally. Furthermore,<br />
continuous introduction of technically advanced products with enhanced efficiency is also supporting<br />
global market growth.<br />
On the other h<strong>and</strong>, high cost, stringent regulatory approval procedures, <strong>and</strong> requirement of experienced
Hexa Reports<br />
<strong>Market</strong> Research Reports <strong>and</strong> Insightful Company Profiles<br />
healthcare professionals to perform TEO procedures are some of the factors that impede market<br />
growth.<br />
Further key findings from the study suggest:<br />
Coils accounted for the largest market share in 2014. Availability of a broad range of coils in various<br />
shapes <strong>and</strong> sizes enables suitable product selection for a variety of cases, making coiling a preferred<br />
treatment for embolization. Moreover affordability of the commercially available devices spurs dem<strong>and</strong><br />
for coiling in occlusion. Thus, reasonable costs together with a broad range of product varieties are<br />
resulting in large market share for coils segment among others.<br />
Accessories including cumulative market revenue generated by devices such as guide wires, catheters,<br />
<strong>and</strong> coiling assist devices was valued as the largest segment among non-coil devices with USD 310.6<br />
million in 2014. Use of accessories across various modes of embolization <strong>and</strong> occlusion is expected to<br />
help in achieving the largest market share.<br />
Request A Sample copy of This Report @ http://www.hexareports.com/sample/104135<br />
North America along with Europe accounted for the largest market share of around 59.0% in 2014.<br />
Presence of advanced healthcare infrastructure, reimbursement coverage, <strong>and</strong> skilled professionals to<br />
perform procedures are some of the factors that will lead to the dominance of these regions in the<br />
world.<br />
Moreover, higher adoption rate for advanced healthcare treatments <strong>and</strong> products coupled with<br />
presence of well-defined regulatory framework are supporting TEO market growth in North America <strong>and</strong><br />
Europe<br />
Asia Pacific TEO devices market is anticipated to show significant growth rate during the forecast period<br />
from 2015 to <strong>2022</strong>. Increasing healthcare expenditure <strong>and</strong> government support to improve healthcare<br />
infrastructure are some of the factors that support TEO market growth in this region.<br />
Rapidly growing medical tourism industry is attracting global cancer patients to the emerging countries<br />
of Asia Pacific. As a result, dem<strong>and</strong> for TEO in Asia Pacific is anticipated to grow swiftly during the<br />
forecast period.<br />
Brazil was the highest revenue generating regional market in Latin America in 2014. Improving<br />
healthcare services, growing medical tourism industry, <strong>and</strong> availability of regulatory framework in the<br />
country are making Brazil the highest revenue generating TEO market in Latin America.<br />
Global players operating in the TEO market are focusing on market share expansion through mergers<br />
<strong>and</strong> acquisitions. <strong>Market</strong> players are also involved in the introduction of innovative <strong>and</strong> advanced<br />
products to capture the market.
Hexa Reports<br />
<strong>Market</strong> Research Reports <strong>and</strong> Insightful Company Profiles<br />
Key players of this market include Terumo Corporation, Medtronic, Inc., Boston Scientific Corporation,<br />
Stryker Corporation, Cordis Corporation, DePuy Synthes, St. Jude Medical, Cook Medical, Sirtex medical,<br />
<strong>and</strong> Nordian.<br />
Table Of Content<br />
Chapter 1 Methodology <strong>and</strong> Scope<br />
1.1 Research Methodology<br />
1.2 Research Scope & Assumptions<br />
1.3 List of Data Sources<br />
Chapter 2 Executive Summary<br />
Chapter 3 <strong>Transcatheter</strong> <strong>Embolization</strong> <strong>and</strong> <strong>Occlusion</strong> <strong>Devices</strong> Industry Outlook<br />
3.1 <strong>Market</strong> segmentation<br />
3.2 <strong>Market</strong> size <strong>and</strong> growth prospects<br />
3.3 <strong>Transcatheter</strong> <strong>Embolization</strong> <strong>and</strong> <strong>Occlusion</strong> <strong>Devices</strong>: <strong>Market</strong> dynamics<br />
3.4 <strong>Market</strong> driver analysis<br />
3.5 <strong>Market</strong> restraint analysis<br />
3.6 Key Opportunities Prioritized<br />
3.7 <strong>Transcatheter</strong> <strong>Embolization</strong> <strong>and</strong> <strong>Occlusion</strong> <strong>Devices</strong> industry analysis – Porter’s Five Forces Model<br />
3.8 <strong>Transcatheter</strong> embolization <strong>and</strong> occlusion devices – PESTEL <strong>Analysis</strong><br />
Browse All Medical <strong>Devices</strong> <strong>Market</strong> Research Related Reports @<br />
http://www.hexareports.com/category/medical-devices-market<br />
Chapter 4 <strong>Transcatheter</strong> embolization <strong>and</strong> occlusion devices <strong>Product</strong> Outlook<br />
4.1 <strong>Transcatheter</strong> embolization <strong>and</strong> occlusion devices revenue share by product type, 2014 & <strong>2022</strong><br />
4.2 Coils<br />
4.3 Non Coils<br />
Chapter 5 <strong>Transcatheter</strong> <strong>Embolization</strong> <strong>and</strong> <strong>Occlusion</strong> <strong>Devices</strong> Regional Outlook<br />
5.1 <strong>Transcatheter</strong> embolization <strong>and</strong> occlusion devices market share, by region, 2014 & <strong>2022</strong><br />
5.2 North America market estimates <strong>and</strong> forecasts, by segment, 2012 - <strong>2022</strong><br />
5.3 Europe market estimates <strong>and</strong> forecasts, by segment, 2012 - <strong>2022</strong><br />
5.4 Asia Pacific market estimates <strong>and</strong> forecasts, by segment, 2012 - <strong>2022</strong><br />
5.5 Latin America market estimates <strong>and</strong> forecasts, by segment, 2012 - <strong>2022</strong><br />
5.6 Middle East <strong>and</strong> Africa (MEA) market estimates <strong>and</strong> forecasts, by segment, 2012 - <strong>2022</strong><br />
Chapter 6 Competitive L<strong>and</strong>scape<br />
6.1 Boston Scientific Corporation
Hexa Reports<br />
<strong>Market</strong> Research Reports <strong>and</strong> Insightful Company Profiles<br />
6.2 Terumo Corporation<br />
6.3 Medtronic, Inc.<br />
6.4 Merit Medical System<br />
6.5 DePuy Synthes<br />
6.6 Stryker Corporation<br />
6.7 Cordis Corporation<br />
6.8 St. Jude Medical<br />
6.9 Pfizer, Inc.<br />
6.10 Sirtex medical<br />
6.11 Nordian<br />
Browse Full Report @ http://www.hexareports.com/report/transcatheter-embolization-<strong>and</strong>occlusion-devices-market/details<br />
About Us:<br />
Hexa Reports is a market research <strong>and</strong> consulting organization, offering industry reports, custom<br />
research <strong>and</strong> consulting services to a host of key industries across the globe. We offer comprehensive<br />
business intelligence in the form of industry reports which help our clients obtain clarity about their<br />
business environment <strong>and</strong> enable them to undertake strategic growth initiatives.<br />
Contact Information:<br />
Ryan Shaw<br />
Felton Office Plaza,<br />
6265 Highway 9,<br />
Felton, California, 95018,<br />
United States<br />
Phone Number<br />
1-800-489-3075<br />
Email Us: sales@hexareports.com<br />
Our Website: http://www.hexareports.com/<br />
Visit our Blog: http://hexareports.blogspot.com/
Change language